Obese individuals are at increased risk for developing insulin resistance and other comorbidities, including diabetes and cardiovascular disease 1,2 . Although the molecular mechanisms that underlie these associations are not completely defined, dysfunction of cellular organelles such as the ER and mitochondria has emerged as a key event in the alterations that follow nutrient overload 3, 4 . For example, in the liver of obese animals, the ER membrane lipid composition is altered, its capacity to retain Ca 2+ is impaired 5 , and ER protein degradation machinery is suppressed 6 . As a consequence, the unfolded protein response (UPR) is activated, affecting a variety of inflammatory, metabolic and stress-signaling networks directly involved in metabolic diseases 3, 7, 8 . ER stress is also detected in obese humans 9,10 , and interventions that improve ER function have been shown to restore glucose homeostasis in mouse models as well as in obese individuals and people with diabetes [11] [12] [13] .
Obese individuals are at increased risk for developing insulin resistance and other comorbidities, including diabetes and cardiovascular disease 1,2 . Although the molecular mechanisms that underlie these associations are not completely defined, dysfunction of cellular organelles such as the ER and mitochondria has emerged as a key event in the alterations that follow nutrient overload 3, 4 . For example, in the liver of obese animals, the ER membrane lipid composition is altered, its capacity to retain Ca 2+ is impaired 5 , and ER protein degradation machinery is suppressed 6 . As a consequence, the unfolded protein response (UPR) is activated, affecting a variety of inflammatory, metabolic and stress-signaling networks directly involved in metabolic diseases 3, 7, 8 . ER stress is also detected in obese humans 9, 10 , and interventions that improve ER function have been shown to restore glucose homeostasis in mouse models as well as in obese individuals and people with diabetes [11] [12] [13] .
It has also been established in humans and mouse models that obesity results in mitochondrial dysfunction in skeletal muscle and adipose tissue, featuring altered oxidative function, ultrastructure abnormalities and increased oxidative stress [14] [15] [16] [17] [18] [19] [20] . In the liver, although there is variability between studies, obesity is associated with altered oxidative capacity and excessive oxidative stress both in humans and in mice [21] [22] [23] [24] . However, the degree of mitochondrial defects, the underlying molecular mechanisms and the consequences for systemic metabolic control are not well established 4, 14, [17] [18] [19] [20] .
Because of the distinct roles that ER and mitochondria play in the cell, the metabolic impacts of ER and mitochondrial dysfunction have largely been viewed and studied independently. However, these organelles physically and functionally interact and are able to regulate each other's function 25 . The sites of physical communication between ER and mitochondria, defined as MAMs, are conserved structures found across eukaryotic phyla and are key determinants of cell survival and death through the transfer of Ca 2+ and other metabolites 25 . In addition, this subdomain of the ER is responsible for the biosynthesis of two abundant phospholipids, phosphatidylcholine and phosphatidylethanolamine 25 . Recently, it was also shown that MAMs are important for autophagy by regulating autophagosome formation 26 and for mitochondrial dynamics by marking sites of mitochondrial fission 27 . Thus, the function or dysfunction of one organelle can profoundly affect the other, but the relevance of this interaction to obesity-related cellular dysfunction and metabolic homeostasis has not been studied.
Here, we show that obesity drives an abnormal increase in MAM formation, which results in increased Ca 2+ flux from the ER to mitochondria in the liver. The mitochondrial Ca 2+ overload is accompanied by increased mitochondrial reactive oxygen species (ROS) production and impairment of metabolic homeostasis. Suppression of two distinct proteins critical for ER-mitochondrial apposition and Ca 2+ flux, inositol 1,4,5-trisphosphate receptor, type 1 (IP3R1) and phosphofurin acidic cluster sorting protein 2 (PACS-2), resulted in improved cellular homeostasis and glucose metabolism in obese animals, suggesting that this mechanism is crucial for metabolic health and could represent a new therapeutic target for metabolic disease.
RESULTS

Higher hepatic ER-mitochondrial contact sites in obesity
In order to investigate ER and mitochondrial morphology and their physical interaction in obesity, we first used transmission electron microscopy (TEM) to examine liver sections collected from both genetic (ob/ob) and dietary (high-fat diet, HFD) models of obesity. In both models this analysis was performed in the context of established obesity: in 8-to 12-week-old ob/ob mice and in mice after 16 weeks of HFD feeding. We observed that the ER membrane displayed a disorganized morphology in livers derived from obese animals along with a markedly higher degree of ER apposition to mitochondria (Fig. 1a-d and Supplementary Fig. 1a,c) . Detailed quantitative analysis (described in Supplementary Fig. 1b ) of liver sections from each experimental group (ten sections per animal, five different animals per group) demonstrated that the proportion of the ER in close contact with mitochondria relative to total ER content was significantly greater in the livers of both ob/ob and HFD mice than in lean controls (Fig. 1e) . This finding was further substantiated by TEM images of isolated crude mitochondrial pellets that revealed mitochondria of obese animals to be more frequently attached to the ER than mitochondria collected from lean controls ( Supplementary Fig. 2a,b) . We also employed organelle-targeted fluorescent proteins as an additional strategy to investigate the alterations in ER-mitochondria juxtaposition. For this, we expressed mitochondria-targeted GFP and ER-targeted DsRed proteins in the livers of lean and ob/ob mice through adenoviral gene delivery and performed image analysis in isolated primary hepatocytes from these animals 24 h after the isolation. We used in vivo expression of the fluorescent proteins rather than transient transfection following primary cell isolation because hepatocyte metabolism changes quickly after isolation. Obese mice showed a greater degree of colocalization between ER and mitochondria in liver cells compared to lean controls ( Fig. 1f and Supplementary  Fig. 3a,b) , as revealed by significantly increased Manders's colocalization coefficient between the organelle-targeted fluorescent markers ( Fig. 1f and Supplementary Fig. 3c) . We also observed a lower level of ER membrane abundance in livers derived from obese animals and a disorganized ER morphology compared with lean counterparts. We performed an extensive morphometric analysis to acquire quantitative comparisons (described in detail in Supplementary Fig. 1b,c) . ER content was 50% and 35% lower in liver cells from ob/ob and HFD mice, respectively, compared with their lean controls (Fig. 1g) . This finding is consistent with the measurement of ER area as percentage of total cell area, which was lower in hepatocytes derived from obese mice than in those derived from lean mice (Supplementary Fig. 1d,e) . As an independent readout of ER content, we also measured the level of calreticulin, a known ER marker, and found that it was lower in both ob/ob mouse-and HFD mouse-derived livers compared to control livers ( Supplementary Fig. 4a ).
The reduction in ER content in obesity was somewhat unexpected because, in the context of ER stress, the ER is thought to morphologically rearrange and expand in order to accommodate protein folding demands and reestablish homeostasis 28 . In our analysis, this predicted adaptive response was clearly defective in the context of established obesity. Hepatic mitochondrial content was also lower in ob/ob mice than in control mice, as measured by TEM (Fig. 1h) , mtDNA content ( Supplementary Fig. 4b ) and COXIV expression ( Supplementary  Fig. 4c ). In addition, three-dimensional (3D) reconstruction of serialsection TEMs revealed that mitochondria from the liver of obese mice were rounder and swollen compared to the tubular mitochondria npg observed in the liver of lean animals, in accordance with previous findings 19 (Fig. 1i,  Supplementary Fig. 2c and Supplementary Movies 1-4) . Taken together, our results collected from multiple mouse models through independent means of quantitative analysis indicate that obesity leads to alterations in hepatic ER and mitochondrial structure and enhanced MAM formation.
Next, we asked whether the alterations in ER and mitochondrial morphology and interaction are an early event during the development of obesity or occur as a consequence of the pathological state triggered by overnutrition. We first examined the ER and mitochondrial morphology by TEM in livers derived from lean mice and mice fed HFD for just 4 weeks. Short-term HFD was sufficient to induce ER reorganization (Fig. 2a) , lower ER content (Fig. 2b) and significantly higher ER-mitochondria interactions (Fig. 2c) , but it did not induce significant changes in total mitochondrial content (Fig. 2d) .
In order to determine whether changes in ER morphology and MAM content result from ER stress, dysfunction or both, we also examined the effect of acute ER stress in the liver in vivo by administration of 0.5 µg per g body weight of tunicamycin for 6 and 24 h in lean mice. Tunicamycin treatment resulted in a higher degree of phosphorylation of eukaryotic initiation factor 2α and c-Jun N-terminal kinase (JNK) and higher expression of ATF4 and GRP78, classical markers of UPR activation (Fig. 2e) . Interestingly, after 6 h of tunicamycin treatment we observed a markedly higher degree of MAMs in the liver (Fig. 2f) . This finding is in line with a previous report showing that ER stress induced by tunicamycin induced more MAMs in vitro 29 . After 24 h, however, there were severe structural defects, with notable ER dilation and disorganization (Fig. 2f) . Taken together, these results suggest that greater MAM formation is a generalized and early response to ER stress.
Altered hepatic ER-mitochondrial protein expression in obesity
MAMs have a key regulatory role in several cellular functions, including the transfer of Ca 2+ and lipids from ER to mitochondria 25 . This subdomain of the ER is enriched in specific proteins such as the Ca 2+ channel IP3R 25, 30 , the mitochondrial-ER tether proteins mitofusin-2 (Mfn2) (ref. 31 ) and PACS-2 (ref. 32) , chaperones such as sigma 1 receptor (Sig1R) 33 and calnexin, and proteins involved in phospholipid metabolism 25 (Fig. 3a) . To explore the possible functional consequences of increased ER-mitochondrial contact in obesity, we examined the expression of MAM-enriched proteins in liver lysates from lean, DIO and ob/ob mice. There was a markedly higher expression of proteins involved in Ca 2+ transport, such as IP3R1 and IP3R2 and Sig1R, in samples from obese mice, along with PACS-2 protein levels ( Fig. 3b) . We found no significant differences in Mfn2 levels. In these experiments, we validated the specificity of the antibodies by employing loss-of-function models ( Supplementary Fig. 5 ).
We then performed Percoll-based subcellular fractionation of liver tissues to collect enriched fractions of mitochondria, ER and MAM and verified the preparations by western blot analysis. Cytochrome C was enriched in mitochondrial fractions, IP3R1 and sarcoendoplasmic reticulum Ca 2+ transport ATPase (SERCA) were preferentially found in the bulk ER, calnexin and protein disulfide isomerase (PDI) were equally distributed between MAM and bulk ER, whereas Sig1R is found preferentially at the MAM (Fig. 3c) . GRP75, the mitochondrial stress protein, was found mainly in the mitochondria but was also detected in the MAM fraction, as has been described 34 . We then verified that the levels of IP3R1 and IP3R2 were significantly higher in MAMs of obese animals than in those of lean controls (Fig. 3d) . The level of PACS-2 was also higher in samples derived from HFD-fed mice than in those from lean controls (Fig. 3d) . Although found in similar levels in total lysates, Mfn2 levels were greater in the MAM fractions derived from obese animals than in those from lean controls (Fig. 3d) , suggesting a possible redistribution of this protein from the mitochondrial membrane to the MAMs. Altogether, these results not only further substantiated our morphological and microscopic observation of a larger number of ER-mitochondrial contact sites in obesity but also suggested a greater density of anchoring proteins and components involved in Ca 2+ transport at these sites.
MAM enrichment in obesity and mitochondrial calcium overload
In MAMs, IP3R resides in close proximity to voltage-dependent anion channel, an ion channel located in the outer mitochondrial membrane. This structure facilitates the uptake of Ca 2+ into the mitochondrial matrix through the low-affinity mitochondrial Ca 2+ Fig. 6b ) despite the higher [Ca 2+ ] m peak in cells from obese mice (Fig. 4c,d ). These observations indicate that in hepatocytes, obesity leads to more Ca 2+ transport from the ER through the MAM connections, resulting in elevated mitochondrial Ca 2+ (Supplementary Fig. 6c ).
Within the mitochondrial matrix, a transient increase in Ca 2+ level activates matrix enzymes and stimulates oxidative phosphorylation, but sustained exposure to high Ca 2+ concentration is often detrimental for mitochondrial function 37 . In primary hepatocytes from ob/ob mice we observed decreased basal oxygen consumption and diminished response to the uncoupling agent FCCP, a sign of mitochondrial dysfunction (Fig. 4f,g ). Additionally, we observed a moderately but significantly lower mitochondrial membrane potential (Fig. 4h ) and higher ROS levels (Fig. 4i) in hepatocytes from obese animals, as measured by tetramethyl rhodamine methyl ester (TMRM) and MitoSOX fluorescence, respectively. These data, together with the altered mitochondrial morphology detected in liver tissue, reveal that in obese animals, high [Ca 2+ ] m is associated with mitochondrial dysfunction.
Experimental induction of MAMs accelerates metabolic decline
In an attempt to mechanistically connect increased MAM content in obesity with mitochondrial Ca 2+ overload, dysfunction and altered cellular and metabolic homeostasis, we asked whether forcing the ER-mitochondria interaction is sufficient to cause mitochondrial Ca 2+ overload and stress in lean, otherwise healthy, animals. To test this hypothesis, we used a recombinant construct encoding a synthetic linker 38 that increases ER-mitochondria contact sites (Fig. 5a) . In order to validate the efficacy of the construct, we first expressed the linker in hepatocyte-derived mouse Hepa1-6 cells. Twenty-four hours following transfection, we sorted the cells on the basis of RFP fluorescence. TEM analysis confirmed that linker expression was associated with a higher degree of contacts between the ER and mitochondria (Fig. 5a) . These cells remained viable throughout the experiments uniporter (MCU) 25, 30, 35 . Identifying a greater degree of MAMs enriched with Ca 2+ regulatory proteins in fatty livers led us to postulate that abnormal Ca 2+ transport from ER to mitochondria may occur in obesity, with deleterious consequences for mitochondrial function. To address this hypothesis, we first assessed mitochondrial Ca 2+ dynamics in obesity by expressing a mitochondria-targeted Ca 2+ fluorescence resonance energy transfer (FRET) reporter 36 in the liver of lean and ob/ob mice through adeno-associated viral delivery (procedure described in Fig. 4a) . Quantitative single-cell imaging of mitochondrial Ca 2+ levels in isolated hepatocytes revealed that mitochondria from obese animals contained a significantly (P < 0.01) higher Ca 2+ concentration ([Ca 2+ ] m ) at baseline (Fig. 4b) . In addition, we detected a higher mitochondrial Ca 2+ uptake following stimulation of ER Ca 2+ release with ATP in primary hepatocytes from obese mice relative to those collected from lean counterparts (Fig. 4c,d) . In a complementary approach, we treated primary hepatocytes from lean and obese mice with carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP), which causes disruption of the mitochondrial membrane potential followed by release of mitochondrial Ca 2+ to the cytosol. Addition of FCCP to hepatocytes from obese mice resulted in greater cytosolic Ca 2+ content compared to lean cells, as measured by Fura2-AM (Fig. 4e) . Notably, the expression of MCU, the mitochondria Ca 2+ uniporter, was also higher in the ob/ob liver tissue, although no difference was found in HFD-fed animals at 16 weeks (Supplementary Fig. 4d ). Taken together, these results show that in the setting of obesity, hepatic mitochondria are overloaded with Ca 2+ , suggesting a previously unrecognized mechanism of mitochondrial dysfunction in the liver of obese animals. To evaluate whether higher [Ca 2+ ] m results from IP3R-mediated ER Ca 2+ release to the cytosol followed by mitochondrial uptake or by direct transport through MAM junctions, we analyzed cytosolic Ca 2+ dynamics in response to IP3R stimulation in primary hepatocytes from lean and ob/ob mice using Fura-2AM. Baseline cytosolic Ca 2+ concentration was significantly (P < 0.01) higher in cells from obese mice (Supplementary Fig. 6a ). However, ATP stimulation led to a similar cytosolic Ca 2+ rise in hepatocytes from lean and obese animals npg (48 h) with no gross phenotypic changes (Supplementary Fig. 7a ) or signs of cell death, as measured by annexin staining followed by FACS analysis (Fig. 5b) . Linker expression was associated with higher peak of ATP-stimulated [Ca 2+ ] m , in line with more ER-mitochondrial interactions that occur upon linker expression (Fig. 5c) . In addition, this experimental enrichment of ER-mitochondrial contacts led to a lower degree of basal and maximal mitochondrial respiration (Fig. 5d) accompanied by higher phosphorylation of JNK and expression of CCAAT-enhancer-binding protein homologous protein (CHOP) (Supplementary Fig. 7b ), both indicators of cellular stress.
We then used adenovirus-mediated gene transfer to express the synthetic linker in the liver of lean animals. Linker expression resulted in more ER-mitochondrial contact sites in the liver compared to the livers of mice expressing control adenovirus (Supplementary Fig. 7c) . However, in 10-week-old lean mice, linker expression did not appear to have any toxic effects, nor did it cause gross morphological changes within the liver (Supplementary Fig. 7d ) or a metabolic phenotype (Supplementary Fig. 7e,f) . This suggests that in a healthy animal, linker expression was well tolerated and not sufficient to disrupt systemic metabolic homeostasis. However, linker expression in mice following a short period (4 weeks) of HFD was associated with a considerably higher degree of ER-mitochondria contact sites (Fig. 5e and Supplementary Fig. 8a) and a markedly higher level of hepatic lipid accumulation compared with controls ( Fig. 5f and Supplementary Fig. 8b ). This was accompanied by lower mitochondrial oxidative function measured following FCCP treatment (Fig. 5g) . At the molecular level, we detected that expression of the linker led to activation of JNK and higher levels of ATF4 and CHOP protein (Fig. 5h) and ATF3 and ATF4 mRNA, with no other changes in UPR markers (Supplementary Fig. 8c) . We also observed impaired insulin-induced phosphorylation of the insulin receptor, IRS1 and AKT in linker-expressing livers (Supplementary Fig. 8d ), which correlated with a moderate but significant impairment in glucose homeostasis, as measured by glucose tolerance test (Fig. 5i) , and with higher liver glucose output, as measured by pyruvate tolerance test (Supplementary Fig. 8e) . To explore the whole-body glucose fluxes with higher precision, we performed hyperinsulinemiceuglycemic clamp studies. Impaired glucose homeostasis was clearly evident during the clamp experiments in linker-expressing animals, which required significantly lower rates of glucose infusion to sustain euglycemia ( Fig. 5j and Supplementary Fig. 8f-h ), indicating that they were relatively insulin insensitive. Clamp hepatic glucose production was significantly higher (Fig. 5j) , also indicating impaired hepatic insulin sensitivity. Taken together, these results demonstrate that increasing ER-mitochondrial interaction in vivo in a context of mild overnutrition is sufficient to cause mitochondrial dysfunction, activation of stress signaling and impaired hepatic control of glucose production, accelerating the decline of glucose homeostasis independent of body weight changes (Supplementary Fig. 8i) .
We then asked whether modulating mitochondrial Ca 2+ uptake by other means, such as by experimentally increasing the level of MCU, previously demonstrated to affect [Ca 2+ ] m (refs. 39,40) would result in physiological alterations similar to those observed upon increased MAM formation. We found that overexpression of MCU in Hepa1-6 cells led to higher levels of oxidative stress and JNK activation without inducing cell death (Supplementary Fig. 9a-c) . Taken together, these data demonstrate that in vitro, [Ca 2+ ] m can be affected either by ER-mitochondrial contact or by expression of MCU and plays an important part in cellular stress responses. npg Silencing IP3R1 and PACS-2 improves metabolism in obese mice Lastly, we asked whether we could improve mitochondrial and cellular function and therefore metabolic homeostasis in obese animals by diminishing ER-mitochondrial Ca 2+ flux or ER-mitochondrial connection. To this end, we used two different but complementary approaches: we decreased ER-mitochondrial Ca 2+ fluxes by suppressing hepatic IP3R1 and decreased ER-mitochondrial physical interaction by suppressing hepatic PACS-2 expression. We achieved a 70% lower level of hepatic IP3R1 expression via the delivery of an adenoviral shRNA in mice without influencing the expression levels of other IP3Rs (Fig. 6a) . This resulted in a modest but significant improvement in mitochondrial maximal oxidative capacity (Fig. 6b) .
In addition, IP3R1 knockdown coincided with lower cellular stress, as measured by phosphorylation of JNK (Fig. 6c) , and an improvement in insulin signaling capacity (Fig. 6d) . These local changes in mitochondrial Ca 2+ flux in the liver also improved systemic glucose tolerance (Fig. 6e) . These findings support our postulate that IP3R1-mediated ER-mitochondrial Ca 2+ transport is crucial in the maintenance of proper glucose metabolism. To further explore the functional importance of ER-mitochondria interactions, we targeted PACS-2, an integral MAM protein upregulated in obesity (Fig. 3b,e) . PACS-2 has previously been shown to be involved in MAM formation and interorganelle communication 32, 41 . Using adenoviral shRNA delivery, we achieved nearly 60% knockdown of PACS-2 in ob/ob mice (Fig. 6f) . Deletion of PACS-2 in cells has been shown to lead to a significant reduction in ER-mitochondria connection and protects against apoptosis 32 . We found that knockdown of PACS-2 resulted in lower JNK phosphorylation (Fig. 6f) and higher mitochondrial maximal respiration with no alterations in basal mitochondria respiration (Fig. 6g) . Reduction of PACS-2 levels also resulted in improved insulin sensitivity (Fig. 6h) , enhanced systemic glucose tolerance (Fig. 6i) and improved liver steatosis (Supplementary Fig. 9d,e) . Taken together, these loss-of-function approaches support the concept that targeting the structural or functional components of MAMs may be an effective strategy to improve glucose homeostasis in the context of obesity. Lastly, we asked whether the changes we observed in the context of obesity were unique to the liver. In agreement with previous reports 15, 42, 43 , we found that in the soleus muscle, mitochondrial morphology was altered and the expression of MAM-enriched proteins was higher in ob/ob mice compared to lean controls (Supplementary Fig. 10) , suggesting that the mechanisms described here may also contribute to cellular dysfunction in npg muscle. However, a more detailed analysis of MAM formation and function in muscle will be required to fully understand the role of these structural changes in insulin resistance in obesity.
DISCUSSION
We have recently shown that aberrant Ca 2+ handling in the ER is one of the primary causes of hepatic ER dysfunction and stress in obesity 5 .
Here, we demonstrate that altered Ca 2+ signaling through the MAMs has a fundamental role in connecting ER stress to mitochondrial dysfunction in obesity, for which plausible mechanisms have been elusive. Our extensive morphological, biochemical and physiological analyses lead us to propose a model in which high nutrient and energy intake leads to increased MAM formation in the liver as an early event in the course of the development of obesity and metabolic disease. Increased MAM formation drives higher Ca 2+ accumulation in the mitochondria that, in turn, leads to impairment in mitochondrial oxidative capacity, increased ROS generation, cellular stress, impaired insulin action in the liver and abnormal glucose metabolism (Fig. 6j) .
We have also observed that induction of acute ER stress such as that triggered by short-term tunicamycin treatment causes a major rearrangement of the ER around the mitochondria, in accordance with earlier findings in vitro 29 . These data, together with our findings that the increase in MAM formation is an early event upon HFD feeding, suggest that increasing MAM formation may be a short-term adaptive process driven by stress conditions to boost mitochondrial function and lipid synthesis. It is also possible that there are dynamic fluctuations in these interactions during physiological changes in metabolic exposures and ER function to support specific metabolic adaptations. In obesity, however, chronic maintenance of these connections leads to undesirable side effects such as mitochondrial Ca 2+ overload. Indeed, in our experiments, increasing MAM formation in the absence of additional stressors was well tolerated and did not affect metabolic homeostasis. However, in the context of even a brief HFD intervention, experimental enrichment of ER-mitochondria interactions accelerated the progression of obesity-related pathologies such as hepatic steatosis and glucose intolerance. Glucose tolerance test in mice expressing shScramble or shPACS-2, n = 7 for shScramble and 9 for shPACS-2. (j) A schematic diagram illustrating that unlike lean, insulin sensitive mice, in the early development of obesity-induced metabolic disease in mice there is increased MAM formation in the liver. Increased MAM formation drives higher Ca 2+ transfer from ER (via IP3R1) to the mitochondria, leading to Ca 2+ overload, which in turn leads to impairment in mitochondrial oxidative capacity, increased ROS generation, cellular stress, impaired insulin action in the liver and abnormal glucose metabolism. All data are mean ± s.e.m., *P < 0.05, Student's t-test. The regulation of mitochondrial function by Ca 2+ is complex, and the outcomes for cellular homeostasis depend on the maintenance of Ca 2+ concentration within a very narrow range. Transient fluctuations in mitochondrial Ca 2+ stimulate the tricarboxylic acid cycle and oxidative phosphorylation, maintaining optimal cellular bioenergetics 37 . Accordingly, cells deficient in all three IP3Rs display compromised mitochondrial function as a result of diminished mitochondrial Ca 2+ uptake 44 . Also, interventions that decrease ER-mitochondrial interaction below physiological thresholds, such as tissue-specific deletion of Mfn2 in liver 45 and hypothalamus 46 , lead to mitochondrial dysfunction and insulin and leptin resistance, respectively. Although these experiments do not specifically address the regulation of ERmitochondria Ca 2+ flux due to the pleiotropic functions of the targeted molecules, they indicate that the proper maintenance of MAMs and Ca 2+ flux is essential for mitochondrial function and metabolic homeostasis.
We also showed here that the downregulation of key molecules involved in ER-mitochondria connection and Ca 2+ flux such as IP3R1 and PACS-2 results in improved mitochondrial respiration, decreased cellular stress and enhanced glucose tolerance in obese animals. Neither IP3R1 nor PACS-2 is exclusively expressed in the MAM, and thus targeting these molecules may result in alterations to cellular function outside the MAM. For example, it is known that IP3R1 also regulates cytosolic Ca 2+ flux; thus, alternative explanations for our observation of improved glucose homeostasis following IP3R knockdown should be considered. Indeed, it was recently reported that in the liver, IP3R regulates systemic glucose metabolism by increasing cytosolic Ca 2+ and glucagon signaling in hepatocytes, and reduced IP3R1 levels consequently decreased glucose production 47, 48 . These results are consistent with our findings. However, the effects of hepatic IP3R1 suppression on oxygen consumption rate (OCR) observed here strongly suggest that altered mitochondrial function also contributes to the metabolic phenotype in vivo. Furthermore, producing metabolic improvements by these two independent interventions modulating different aspects of ER-mitochondria interactions strongly supports their importance in organelle and metabolic homeostasis.
The effect of MAM regulation on metabolism is likely to result from the engagement of multiple pathways and multiple structural components. Interventions that disrupt individual MAM components may thus only partially recapitulate the impact of overall MAM function in cellular and organismal physiology. Also, MAM regulation affects not only Ca 2+ flux but also lipid biosynthesis, autophagy and mitochondrial fission [25] [26] [27] . As all of these phenomena are altered in obesity, it is possible that alteration of MAMs has a more pleiotropic effect in the obese condition as well as in stage-specific metabolic pathologies mediated distinctly by different molecular components, and these processes should be explored in future studies.
During the review of this manuscript, an independent group reported that HFD feeding leads to diminished ER-mitochondria contact sites in liver and primary hepatocytes employing a different methodology 49 . Of note, MAM formation and content in the liver are highly plastic depending on metabolic status, age and stress condition, and thus the contrasting conclusions may reflect both differing experimental parameters and analytical methodology, including in vitro assays. As liver size and lipid content increase in obesity, total MAM content should be evaluated relative to alterations in tissue mass and composition. These issues notwithstanding, cumulative evidence supports the concept the MAM regulation has a major impact on glucose homeostasis 45, 46 .
The association between defective mitochondrial function, insulin resistance and type 2 diabetes has been a topic of intense investigation and debate in the field [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Most studies have been performed in human skeletal muscle, where insulin resistance is linked to impaired mitochondrial oxidative function and density 15, 20 . However, whether these alterations cause or result from insulin resistance is presently unclear. As we found that skeletal muscle mitochondrial morphology is altered in soleus muscle of ob/ob mice and expression of MAM-enriched proteins is increased, altered sarcoplasmic reticulum-mitochondria Ca 2+ fluxes may also have a role in obesityrelated mitochondrial dysfunction in muscle.
Our observations may have implications beyond obesity. Enhanced MAM function and increased ER-mitochondrial interaction have been observed in neurodegenerative diseases such as gangliosidosis 50 and Alzheimer's disease 51 and also in senescence 52 . Notably, Alzheimer's disease is also associated with insulin resistance in the brain 53 and shares numerous molecular features with obesity including ER stress, JNK activation and organelle dysfunction, as well as aging. Therefore, we suggest that therapies that restore the proper function of ER-mitochondrial interface may be a useful approach in the treatment of multiple metabolic diseases with these mechanistic features.
METHODS
Methods and any associated references are available in the online version of the paper. 
